{"id":"https://openalex.org/W4416637085","doi":"https://doi.org/10.1183/13993003.congress-2025.pa3964","title":"Rifampicin leads to subtherapeutic azithromycin exposures in NTM disease treatment","display_name":"Rifampicin leads to subtherapeutic azithromycin exposures in NTM disease treatment","publication_year":2025,"publication_date":"2025-09-27","ids":{"openalex":"https://openalex.org/W4416637085","doi":"https://doi.org/10.1183/13993003.congress-2025.pa3964"},"language":null,"primary_location":{"id":"doi:10.1183/13993003.congress-2025.pa3964","doi":"https://doi.org/10.1183/13993003.congress-2025.pa3964","is_oa":false,"landing_page_url":"https://doi.org/10.1183/13993003.congress-2025.pa3964","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Tuberculosis and non-tuberculous mycobacterial diseases","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Michael Rodgers","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I145872427","display_name":"Radboud University Nijmegen","ror":"https://ror.org/016xsfp80","country_code":"NL","type":"education","lineage":["https://openalex.org/I145872427"]},{"id":"https://openalex.org/I2802934949","display_name":"Radboud University Medical Center","ror":"https://ror.org/05wg1m734","country_code":"NL","type":"funder","lineage":["https://openalex.org/I2802934949"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Michael Rodgers","raw_affiliation_strings":["1Radboudumc, department of Medical Microbiology, Nijmegen, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Radboudumc, department of Medical Microbiology, Nijmegen, Netherlands","institution_ids":["https://openalex.org/I145872427","https://openalex.org/I2802934949"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032363032","display_name":"Victor N\u00e6stholt Dahl","orcid":"https://orcid.org/0000-0003-2965-6348","observed_orcids":["https://orcid.org/0000-0003-2965-6348"]},"institutions":[{"id":"https://openalex.org/I2802335433","display_name":"Aarhus University Hospital","ror":"https://ror.org/040r8fr65","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I2802335433"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Victor Dahl","raw_affiliation_strings":["2Aarhus University Hospital, Department of Infectious Diseases, Aarhus, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Aarhus University Hospital, Department of Infectious Diseases, Aarhus, Denmark","institution_ids":["https://openalex.org/I2802335433"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030595352","display_name":"Ralf Stemkens","orcid":"https://orcid.org/0009-0008-6912-4163","observed_orcids":["https://orcid.org/0009-0008-6912-4163"]},"institutions":[{"id":"https://openalex.org/I145872427","display_name":"Radboud University Nijmegen","ror":"https://ror.org/016xsfp80","country_code":"NL","type":"education","lineage":["https://openalex.org/I145872427"]},{"id":"https://openalex.org/I2802934949","display_name":"Radboud University Medical Center","ror":"https://ror.org/05wg1m734","country_code":"NL","type":"funder","lineage":["https://openalex.org/I2802934949"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Ralf Stemkens","raw_affiliation_strings":["3Radboudumc, department of Pharmacy, Nijmegen, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Radboudumc, department of Pharmacy, Nijmegen, Netherlands","institution_ids":["https://openalex.org/I145872427","https://openalex.org/I2802934949"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040407230","display_name":"Arjan van Laarhoven","orcid":"https://orcid.org/0000-0002-6607-4075","observed_orcids":["https://orcid.org/0000-0002-6607-4075"]},"institutions":[{"id":"https://openalex.org/I145872427","display_name":"Radboud University Nijmegen","ror":"https://ror.org/016xsfp80","country_code":"NL","type":"education","lineage":["https://openalex.org/I145872427"]},{"id":"https://openalex.org/I2802934949","display_name":"Radboud University Medical Center","ror":"https://ror.org/05wg1m734","country_code":"NL","type":"funder","lineage":["https://openalex.org/I2802934949"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Arjan Van Laarhoven","raw_affiliation_strings":["4Radboudumc, department of Internal Medicine, Nijmegen, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Radboudumc, department of Internal Medicine, Nijmegen, Netherlands","institution_ids":["https://openalex.org/I145872427","https://openalex.org/I2802934949"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041574334","display_name":"Wouter Hoefsloot","orcid":"https://orcid.org/0000-0003-1007-1075","observed_orcids":["https://orcid.org/0000-0003-1007-1075"]},"institutions":[{"id":"https://openalex.org/I145872427","display_name":"Radboud University Nijmegen","ror":"https://ror.org/016xsfp80","country_code":"NL","type":"education","lineage":["https://openalex.org/I145872427"]},{"id":"https://openalex.org/I2802934949","display_name":"Radboud University Medical Center","ror":"https://ror.org/05wg1m734","country_code":"NL","type":"funder","lineage":["https://openalex.org/I2802934949"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Wouter Hoefsloot","raw_affiliation_strings":["5Radboudumc, department of Respiratory Diseases, Nijmegen, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Radboudumc, department of Respiratory Diseases, Nijmegen, Netherlands","institution_ids":["https://openalex.org/I145872427","https://openalex.org/I2802934949"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010141975","display_name":"Jakko van Ingen","orcid":"https://orcid.org/0000-0002-0581-2003","observed_orcids":["https://orcid.org/0000-0002-0581-2003"]},"institutions":[{"id":"https://openalex.org/I145872427","display_name":"Radboud University Nijmegen","ror":"https://ror.org/016xsfp80","country_code":"NL","type":"education","lineage":["https://openalex.org/I145872427"]},{"id":"https://openalex.org/I2802934949","display_name":"Radboud University Medical Center","ror":"https://ror.org/05wg1m734","country_code":"NL","type":"funder","lineage":["https://openalex.org/I2802934949"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Jakko van Ingen","raw_affiliation_strings":["1Radboudumc, department of Medical Microbiology, Nijmegen, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Radboudumc, department of Medical Microbiology, Nijmegen, Netherlands","institution_ids":["https://openalex.org/I145872427","https://openalex.org/I2802934949"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5113258748","display_name":"Rob Aarnoutse","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I145872427","display_name":"Radboud University Nijmegen","ror":"https://ror.org/016xsfp80","country_code":"NL","type":"education","lineage":["https://openalex.org/I145872427"]},{"id":"https://openalex.org/I2802934949","display_name":"Radboud University Medical Center","ror":"https://ror.org/05wg1m734","country_code":"NL","type":"funder","lineage":["https://openalex.org/I2802934949"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Rob Aarnoutse","raw_affiliation_strings":["3Radboudumc, department of Pharmacy, Nijmegen, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Radboudumc, department of Pharmacy, Nijmegen, Netherlands","institution_ids":["https://openalex.org/I145872427","https://openalex.org/I2802934949"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"PA3964","last_page":"PA3964"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11316","display_name":"Mycobacterium research and diagnosis","score":0.9628999829292297,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11316","display_name":"Mycobacterium research and diagnosis","score":0.9628999829292297,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.020400000736117363,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.011300000362098217,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/rifampicin","display_name":"rifampicin","score":0.9950000047683716},{"id":"https://openalex.org/keywords/azithromycin","display_name":"azithromycin","score":0.9869999885559082},{"id":"https://openalex.org/keywords/mycobacterium-avium-complex","display_name":"Mycobacterium avium complex","score":0.8830000162124634},{"id":"https://openalex.org/keywords/nontuberculous-mycobacterial-lung-disease","display_name":"nontuberculous mycobacterial lung disease","score":0.8980000019073486},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.8730000257492065},{"id":"https://openalex.org/keywords/cyp3a4-induction","display_name":"CYP3A4 induction","score":0.9330000281333923},{"id":"https://openalex.org/keywords/drug-exposure","display_name":"drug exposure","score":0.5730000138282776},{"id":"https://openalex.org/keywords/therapeutic-drug-monitoring","display_name":"therapeutic drug monitoring","score":0.8619999885559082},{"id":"https://openalex.org/keywords/ethambutol","display_name":"ethambutol","score":0.6800000071525574},{"id":"https://openalex.org/keywords/area-under-the-curve","display_name":"area under the curve","score":0.5910000205039978},{"id":"https://openalex.org/keywords/peak-concentration","display_name":"peak concentration","score":0.6520000100135803},{"id":"https://openalex.org/keywords/bioequivalence","display_name":"bioequivalence","score":0.7979999780654907}],"concepts":[{"id":"https://openalex.org/C2778907293","wikidata":"https://www.wikidata.org/wiki/Q165399","display_name":"Azithromycin","level":3,"score":0.9728000164031982},{"id":"https://openalex.org/C2778607973","wikidata":"https://www.wikidata.org/wiki/Q422652","display_name":"Rifampicin","level":3,"score":0.9614999890327454},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8385999798774719},{"id":"https://openalex.org/C2776228421","wikidata":"https://www.wikidata.org/wiki/Q412318","display_name":"Ethambutol","level":4,"score":0.6179999709129333},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.49470001459121704},{"id":"https://openalex.org/C3019249092","wikidata":"https://www.wikidata.org/wiki/Q274493","display_name":"Antibacterial agent","level":3,"score":0.4851999878883362},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4449999928474426},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.3910999894142151},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.3799999952316284},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.30869999527931213},{"id":"https://openalex.org/C2781363766","wikidata":"https://www.wikidata.org/wiki/Q7251505","display_name":"Protein synthesis inhibitor","level":4,"score":0.27149999141693115},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.2711000144481659},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.26809999346733093},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.2535000145435333}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1183/13993003.congress-2025.pa3964","doi":"https://doi.org/10.1183/13993003.congress-2025.pa3964","is_oa":false,"landing_page_url":"https://doi.org/10.1183/13993003.congress-2025.pa3964","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Tuberculosis and non-tuberculous mycobacterial diseases","raw_type":"proceedings-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":[],"abstract_inverted_index":{"Introduction:":[0],"Recommended":[1],"azithromycin,":[2],"ethambutol":[3],"and":[4,35,48,73,104,123,190,198,202,224],"rifampicin":[5,55,88,106,168,192,207,226],"regimens":[6],"for":[7,156,165],"Mycobacterium":[8],"avium":[9],"complex":[10],"(MAC)":[11],"disease":[12,46,79],"have":[13,24],"high":[14],"failure":[15],"rates.":[16],"Azithromycin":[17],"peak":[18,74],"serum":[19],"concentrations":[20,76,119,187],"(Cmax)":[21,75],"<0.4":[22],"mg/l":[23],"been":[25],"associated":[26],"with":[27,103,122,189],"treatment":[28],"failure.":[29],"Rifampicin":[30,211],"induces":[31],"CYP3A4":[32],"metabolic":[33],"enzymes":[34],"decreases":[36],"azithromycin":[37,41,57,63,90,118,144,157,186,214],"exposures.":[38],"We":[39,60,127],"studied":[40],"exposures":[42,215],"in":[43,77,101],"a":[44,95,109],"MAC":[45,78],"population":[47],"assessed":[49,93],"the":[50,153],"effect":[51,86],"of":[52,54,87,196],"co-administration":[53,212],"on":[56,89,98],"exposure.":[58],"Methods:":[59],"collected":[61],"plasma":[62],"area-under-the-curve":[64],"from":[65,81],"0":[66],"to":[67,114,216,229],"6":[68],"hours":[69],"after":[70],"administration":[71],"(AUC0-6)":[72],"patients":[80,102,115,130,150,166,183],"2021":[82],"till":[83],"2025.":[84],"The":[85,141],"exposure":[91],"was":[92,112,146,159,172],"using":[94,206],"between-group":[96],"t-test":[97],"log-transformed":[99],"measures":[100],"without":[105,124,167,191],"co-administration.":[107],"Additionally,":[108],"bio-equivalence":[110],"approach":[111],"applied":[113],"who":[116,184],"had":[117,185],"measured":[120,188],"both":[121],"rifampicin.":[125],"Results:":[126],"included":[128],"136":[129],"(49%":[131],"male;":[132],"mean":[133,137,143,155],"age":[134],"60":[135],"years;":[136],"weight":[138],"67":[139],"kg).":[140],"geometric":[142,154,194],"dose":[145],"7.2":[147],"mg/kg.":[148],"In":[149,181],"receiving":[151],"rifampicin,":[152],"AUC0-6":[158,197],"0.90":[160],"mg/L*hours":[161],"vs":[162,175],"1.83":[163],"mg/L*hour":[164],"(49%).":[169],"Similarly,":[170],"Cmax":[171,199],"0.22":[173],"mg/L":[174,177],"0.46":[176],"(48%)":[178],"(all":[179,208],"p<0.001).":[180],"14":[182],"use,":[193],"means":[195],"were":[200],"38%":[201],"42%":[203],"lower":[204],"while":[205],"p\u22640.001).":[209],"Conclusions:":[210],"reduces":[213],"subtherapeutic":[217],"levels.":[218],"Therapeutic":[219],"drug":[220],"monitoring,":[221],"higher":[222],"doses":[223],"replacing":[225],"are":[227],"strategies":[228],"improve":[230],"outcomes.":[231]},"counts_by_year":[],"updated_date":"2026-10-01T08:54:57.152042","created_date":"2025-11-25T00:00:00"}